- Correspondence to Dr Stephen John Oliver, Translational Medicine, Novartis Pharma, Basel 4002, Switzerland;
- Received November 10, 2018
- Revised January 21, 2019
- Accepted February 14, 2019
- First published March 2, 2019.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.